Elevated Akt activation in human cancers can result from its enhanced phosphorylation due to loss of the PTEN tumour suppressor [26] or PP2a, which is now considered to be a tumour suppressor as well since it can also dephosphorylate Akt and thus downregulate its activity [27]. This evidence concerns the gene PTPA and cancer.